Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Reddy, V"" wg kryterium: Autor


Tytuł :
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR® study
Autorzy :
Maziarz, R. T.
Brazauskas, R.
Chen, M.
McLeod, A.
Martino, R.
Wingard, John R
Aljurf, M. D.
Battiwalla, M.
Dvorak, Christopher C.
Geroge, B.
Guinan, E.C.
Hale, G.A.
Lazarus, Hillard M
Lee, Wen-Jane
Liesveld, J. L.
Ramanathan, Muthalagu
Reddy, V.
Savani, Bipin N
Smith, F. O.
Strasfeld, L.
Taplitz, R. A.
Ustun, Celalettin
Boeckh, M. J.
Gea-Banacloche, J.
Lindemans, C. A.
Auletta, Jeffery J
Riches, Marcie L
Pokaż więcej
Temat :
Hematology
surgical procedures, operative
Transplantation
Article
Źródło :
Bone Marrow Transplantation, 52(2), 270. Nature Publishing Group
Bone marrow transplantation
Opis pliku :
image/pdf
Tytuł :
Long-term outcome after intensive therapy with etoposide, melphalan, total body irradiation and autotransplant for acute myeloid leukemia.
Autorzy :
Mollee, P.
Gupta, V.
Song, K.
Reddy, V.
Califaretti, N.
Tsang, R.
Crump, M.
Keating, A.
Pokaż więcej
Temat :
MYELOID leukemia
ETOPOSIDE
ANTINEOPLASTIC agents
BONE marrow diseases
IRRADIATION
AUTOGRAFTS
Źródło :
Bone Marrow Transplantation; Jun2004, Vol. 33 Issue 12, p1201-1208, 8p
Czasopismo naukowe
Tytuł :
Late onset of invasive aspergillus infection in bone marrow transplant patients at a university hospital.
Autorzy :
Grow, W.B.
Moreb, J.S.
Roque, D.
Manion, K.
Leather, H.
Reddy, V.
Khan, S.A.
Finiewicz, K.J.
Nguyen, H.
Clancy, C.J.
Mehta, P.S.
Wingard, J.R.
Pokaż więcej
Temat :
ASPERGILLOSIS
MYCOSES
BONE marrow transplant complications
Źródło :
Bone Marrow Transplantation; 1/1/2002, Vol. 29 Issue 1, p15, 5p, 5 Charts
Czasopismo naukowe
Tytuł :
Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR study.
Autorzy :
Maziarz RT; Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Brazauskas R; CIBMTR, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.; Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA.
Chen M; CIBMTR, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
McLeod AA; Adult Blood and Marrow Stem Cell Transplant Program, Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Martino R; Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Wingard JR; Division of Hematology & Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
Aljurf M; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
Battiwalla M; Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, MD, USA.
Dvorak CC; Department of Pediatrics, University of California San Francisco Medical Center, San Francisco, CA, USA.
Geroge B; Department of Hematology, Christian Medical College, Vellore, India.
Guinan EC; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Hale GA; Department of Hematology/Oncology, All Children's Hospital, St Petersburg, FL, USA.
Lazarus HM; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
Lee JW; BMT Center, Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea.
Liesveld JL; Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Ramanathan M; Division of Hematology and Oncology, Department of Medicine, UMass Memorial Medical Center, Worcester, MA, USA.
Reddy V; Department of Internal Medicine, University of Central Florida College of Medicine, Orlando, FL, USA.
Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Smith FO; University of Cincinnati Cancer Institute, Cincinnati, OH, USA.
Strasfeld L; Infectious Disease Clinic, Oregon Health and Science University, Portland, OR, USA.
Taplitz RA; Infectious Diseases Program, UC San Diego Health, La Jolla, CA, USA.
Ustun C; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA.
Boeckh MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Gea-Banacloche J; Experimental Transplantation and Immunology Branch, National Institutes of Health-National Cancer Institute, Bethesda, MD, USA.
Lindemans CA; Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, Netherlands.
Auletta JJ; Divisions of Hematology/Oncology, Bone Marrow Transplantation and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH, USA.
Riches ML; Division of Hematology/Oncology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2017 Feb; Vol. 52 (2), pp. 270-278. Date of Electronic Publication: 2016 Dec 19.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Aspergillosis*/etiology
Aspergillosis*/mortality
Aspergillosis*/therapy
Aspergillus*
Candida*
Candidiasis*/etiology
Candidiasis*/mortality
Candidiasis*/therapy
Cord Blood Stem Cell Transplantation*
Hematologic Neoplasms*/mortality
Hematologic Neoplasms*/therapy
Registries*
Adolescent ; Adult ; Aged ; Allografts ; Child ; Child, Preschool ; Disease-Free Survival ; Female ; Humans ; Infant ; Male ; Middle Aged ; Survival Rate
Czasopismo naukowe
Tytuł :
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1.
Autorzy :
Fleischhauer K; 1] Institute of Experimental Cellular Therapy, Essen University Hospital, Essen, Germany [2] Unit of Molecular and Functional Immunogenetics, San Raffaele Scientific Institute, Milan, Italy.
Fernandez-Viña MA; Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford University Medical School, Stanford, CA, USA.
Wang T; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA.
Haagenson M; Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA.
Battiwalla M; National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Baxter-Lowe LA; Immunogentics and Transplantation Lab, University of California San Francisco Medical Center, San Francisco, CA, USA.
Ciceri F; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.
Dehn J; National Marrow Donor Program, Minneapolis, MN, USA.
Gajewski J; Oregon Health and Science University, Portland, OR, USA.
Hale GA; Pediatric Hematology/Oncology/BMT, All Children's Hospital, St Petersburg, FL, USA.
Heemskerk MB; Dutch Transplant Foundation, Leiden, The Netherlands.
Marino SR; Department of Pathology, University of Chicago Hospitals, Chicago, IL, USA.
McCarthy PL; Blood and Marrow Transplant, Roswell Park Cancer Institute, Buffalo, NY, USA.
Miklos D; Department of Medicine/Bone Marrow Transplant, Stanford Hospitals and Clinics, Stanford, CA, USA.
Oudshoorn M; Europdonor Foundation, Leiden University Medical Center, Leiden, Netherlands.
Pollack MS; Department of Pathology, University of Texas Health Care System, San Antonio, TX, USA.
Reddy V; Department of Hemaotology/Oncology, University of Florida, Gainesville, FL, USA.
Senitzer D; Hematology/Hematopoietic Cell Transplant, City of Hope National Medical Center, Duarte, CA, USA.
Shaw BE; Anthony Nolan Research Institute, London, UK.
Waller EK; Bone Marrow and Stem Cell Transplant Center, Emory University Hospital, Atlanta, GA, USA.
Lee SJ; Clinical Transplant Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Spellman SR; Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA.
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2014 Sep; Vol. 49 (9), pp. 1176-83. Date of Electronic Publication: 2014 Jun 23.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Epitopes, T-Lymphocyte/*immunology
HLA-DP alpha-Chains/*immunology
HLA-DP beta-Chains/*immunology
Hematopoietic Stem Cell Transplantation/*methods
Transplantation Conditioning/*methods
Adolescent ; Adult ; Child ; Child, Preschool ; Cohort Studies ; Epitope Mapping ; Female ; Humans ; Infant ; Male ; Middle Aged ; Risk ; Unrelated Donors ; Young Adult
Czasopismo naukowe
Tytuł :
Physician perceptions and practice patterns regarding fertility preservation in hematopoietic cell transplant recipients.
Autorzy :
Loren AW; Abramson Cancer Center University of Pennsylvania Medical Center, Philadelphia, PA, USA.
Brazauskas R
Chow EJ
Gilleece M
Halter J
Jacobsohn DA
Joshi S
Pidala J
Quinn GP
Wang Z
Apperley JF
Burns LJ
Hale GA
Hayes-Lattin BM
Kamble R
Lazarus H
McCarthy PL
Reddy V
Warwick AB
Bolwell BJ
Duncan C
Socie G
Sorror ML
Wingard JR
Majhail NS
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2013 Aug; Vol. 48 (8), pp. 1091-7. Date of Electronic Publication: 2013 Feb 18.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
MeSH Terms :
Health Knowledge, Attitudes, Practice*
Fertility Preservation/*methods
Hematopoietic Stem Cell Transplantation/*methods
Practice Patterns, Physicians'/*statistics & numerical data
Adult ; Aged ; Data Collection ; Female ; Fertility Preservation/statistics & numerical data ; Health Care Surveys ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hematopoietic Stem Cell Transplantation/statistics & numerical data ; Humans ; Infertility/prevention & control ; Male ; Middle Aged ; Surveys and Questionnaires ; United States
Czasopismo naukowe
Tytuł :
Second malignancies after autologous hematopoietic cell transplantation in children.
Autorzy :
Danner-Koptik KE; Department of Hematology and Oncology, Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Majhail NS
Brazauskas R
Wang Z
Buchbinder D
Cahn JY
Dilley KJ
Frangoul HA
Gross TG
Hale GA
Hayashi RJ
Hijiya N
Kamble RT
Lazarus HM
Marks DI
Reddy V
Savani BN
Warwick AB
Wingard JR
Wood WA
Sorror ML
Jacobsohn DA
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2013 Mar; Vol. 48 (3), pp. 363-8. Date of Electronic Publication: 2012 Sep 10.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Hematopoietic Stem Cell Transplantation/*statistics & numerical data
Neoplasms, Second Primary/*epidemiology
Survivors/*statistics & numerical data
Adolescent ; Adult ; Child ; Child, Preschool ; Cohort Studies ; Female ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Incidence ; Infant ; Male ; Neoplasms, Second Primary/etiology ; Risk Factors ; Transplantation, Autologous ; Young Adult
Czasopismo naukowe
Tytuł :
Stem cell mobilization in heavily pretreated multiple myeloma patients with prior high dose melphalan and auto-SCT.
Autorzy :
Khaled Y
Al-Hazzouri A
Mizrachi A
Reynolds R
Reddy V
Solh M
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2013 Feb; Vol. 48 (2), pp. 310-1. Date of Electronic Publication: 2012 Jul 09.
Typ publikacji :
Letter
MeSH Terms :
Antineoplastic Agents, Alkylating/*adverse effects
Hematopoietic Stem Cell Mobilization/*methods
Melphalan/*adverse effects
Multiple Myeloma/*blood
Multiple Myeloma/*drug therapy
Stem Cell Transplantation/*methods
Aged ; Antineoplastic Agents, Alkylating/administration & dosage ; Blood Component Removal/methods ; Humans ; Melphalan/administration & dosage ; Middle Aged ; Salvage Therapy
Opinia redakcyjna
Tytuł :
Long-term impact of prior rituximab therapy and early lymphocyte recovery on auto-SCT outcome for diffuse large B-cell lymphoma.
Autorzy :
Stover DG; Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN 37232-5505, USA.
Reddy VK
Shyr Y
Savani BN
Reddy N
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2012 Jan; Vol. 47 (1), pp. 82-7. Date of Electronic Publication: 2011 Feb 28.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Stem Cell Transplantation*
Lymphocytes/*immunology
Lymphoma, Large B-Cell, Diffuse/*mortality
Lymphoma, Large B-Cell, Diffuse/*therapy
Recovery of Function/*immunology
Adult ; Age Factors ; Aged ; Antibodies, Monoclonal, Murine-Derived/therapeutic use ; Antineoplastic Agents/therapeutic use ; Disease-Free Survival ; Female ; Humans ; Lymphoma, Large B-Cell, Diffuse/immunology ; Male ; Middle Aged ; Neoplasm Staging ; Retrospective Studies ; Rituximab ; Survival Rate ; Time Factors ; Transplantation, Autologous
Czasopismo naukowe
Tytuł :
Reduced-intensity conditioning using fludarabine with either antithymocyte globulin and BU, or low-dose TBI allowing allogeneic hematopoietic SCT.
Autorzy :
Cable C; Division of Hematology/Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.
Buzzeo MP
Schold JD
Khan S
Leather H
Moreb J
Jamieson K
Scornik J
Amdur RJ
Wingard JR
Reddy V
Pokaż więcej
Źródło :
Bone marrow transplantation [Bone Marrow Transplant] 2010 Jan; Vol. 45 (1), pp. 31-7. Date of Electronic Publication: 2009 Jun 22.
Typ publikacji :
Journal Article
MeSH Terms :
Antilymphocyte Serum/*administration & dosage
Busulfan/*administration & dosage
Hematopoietic Stem Cell Transplantation/*methods
Myeloablative Agonists/*therapeutic use
Transplantation Conditioning/*methods
Vidarabine/*analogs & derivatives
Whole-Body Irradiation/*methods
Adolescent ; Adult ; Aged ; Clinical Protocols ; Female ; Hematologic Neoplasms/therapy ; Humans ; Male ; Middle Aged ; Prospective Studies ; Vidarabine/therapeutic use
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies